Posaconazole prophylaxis in patients with acute myeloid leukemia: A real life experience from a prospective multicenter observational study

Autor: Metan, G., Etgul, S., Cifticioglu, A., Saba, R., Kilic, A. Ulu, Yilmaz, H., Demir, K., Cag, Y., Unal, D. Kiper, Aksoy, F., Berk, H., Mert, G., Tunccan, O. G., Tombak, A., Delibalta, G., Balkan, I. I., Cavus, Sa, Kandemir, B., Mutlu, B., Inkaya, A. C., Karadogan, I., Leylagul Kaynar, Atay, M. H., Keskin, A., Dursun, F. E., Kurtoglu, E., Saydam, G., Erkut, N., Ozkurt, N. Z., Ozgur, G., Ozsan, H. G., Unsal, Y., Ongoren, S., Sari, F. S., Tiftik, N., Akan, H.

Publikováno v: Web of Science

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::252f2c50719383555de16dcbbc137a7d
https://avesis.erciyes.edu.tr/publication/details/b3404ad7-05b9-4069-9b1b-f042e0e55ffc/oai

Copy-number variations in adult patients with chronic immune thrombocytopenia.

Autor: Yucesan E; Faculty of Medicine, Department of Medical Biology, Bezmialem Vakif University , Istanbul, Turkey., Hatirnaz Ng O; Department of Genetics, Aziz Sancar Institute of Experimental Medicine, Istanbul University , Istanbul, Turkey., Yalniz FF; Cerrahpasa Faculty of Medicine, Division of Haematology, Department of Internal Medicine, Istanbul University-Cerrahpasa , Istanbul, Turkey., Yilmaz H; Cerrahpasa Faculty of Medicine, Division of Haematology, Department of Internal Medicine, Istanbul University-Cerrahpasa , Istanbul, Turkey., Salihoglu A; Cerrahpasa Faculty of Medicine, Division of Haematology, Department of Internal Medicine, Istanbul University-Cerrahpasa , Istanbul, Turkey., Sudutan T; Department of Genetics, Aziz Sancar Institute of Experimental Medicine, Istanbul University , Istanbul, Turkey., Eskazan AE; Cerrahpasa Faculty of Medicine, Division of Haematology, Department of Internal Medicine, Istanbul University-Cerrahpasa , Istanbul, Turkey., Ongoren S; Cerrahpasa Faculty of Medicine, Division of Haematology, Department of Internal Medicine, Istanbul University-Cerrahpasa , Istanbul, Turkey., Baslar Z; Cerrahpasa Faculty of Medicine, Division of Haematology, Department of Internal Medicine, Istanbul University-Cerrahpasa , Istanbul, Turkey., Soysal T; Cerrahpasa Faculty of Medicine, Division of Haematology, Department of Internal Medicine, Istanbul University-Cerrahpasa , Istanbul, Turkey., Ozbek U; Department of Medical Genetics, Acibadem Mehmet Ali Aydinlar University, School of Medicine , Istanbul, Turkey., Sayitoglu M; Department of Genetics, Aziz Sancar Institute of Experimental Medicine, Istanbul University , Istanbul, Turkey., Ar MC; Cerrahpasa Faculty of Medicine, Division of Haematology, Department of Internal Medicine, Istanbul University-Cerrahpasa , Istanbul, Turkey.

Publikováno v: Expert review of hematology [Expert Rev Hematol] 2020 Nov; Vol. 13 (11), pp. 1277-1287. Date of Electronic Publication: 2020 Sep 23.

Epidemiological, clinical, biochemical, and treatment characteristics of brucellosis cases in Turkey.

Autor: Arslan, Mustafa¹ mustafaarslan61@yahoo.com.tr, Ertunç, Barış², Düz, Muhammed Emin³, Menekşe, Elif⁴, Avci, Burak Yasin⁴, Avci, Ecem⁴, Yilmaz, Gürdal⁵

Publikováno v: Journal of Infection in Developing Countries. Jul2024, Vol. 18 Issue 7, p1066-1073. 8p.

Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors.

Autor: Erbilgin Y; a Aziz Sancar Institute of Experimental Medicine Department of Genetics , Istanbul University , Istanbul , Turkey., Eskazan AE; b Division of Haematology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine , Istanbul University , Istanbul , Turkey., Hatirnaz Ng O; a Aziz Sancar Institute of Experimental Medicine Department of Genetics , Istanbul University , Istanbul , Turkey., Salihoglu A; b Division of Haematology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine , Istanbul University , Istanbul , Turkey., Elverdi T; b Division of Haematology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine , Istanbul University , Istanbul , Turkey., Firtina S; a Aziz Sancar Institute of Experimental Medicine Department of Genetics , Istanbul University , Istanbul , Turkey., Tasar O; a Aziz Sancar Institute of Experimental Medicine Department of Genetics , Istanbul University , Istanbul , Turkey., Mercan S; a Aziz Sancar Institute of Experimental Medicine Department of Genetics , Istanbul University , Istanbul , Turkey., Sisko S; a Aziz Sancar Institute of Experimental Medicine Department of Genetics , Istanbul University , Istanbul , Turkey., Khodzhaev K; a Aziz Sancar Institute of Experimental Medicine Department of Genetics , Istanbul University , Istanbul , Turkey., Ongoren S; b Division of Haematology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine , Istanbul University , Istanbul , Turkey., Ar MC; b Division of Haematology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine , Istanbul University , Istanbul , Turkey., Baslar Z; b Division of Haematology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine , Istanbul University , Istanbul , Turkey., Soysal T; b Division of Haematology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine , Istanbul University , Istanbul , Turkey., Sayitoglu M; a Aziz Sancar Institute of Experimental Medicine Department of Genetics , Istanbul University , Istanbul , Turkey., Ozbek U; a Aziz Sancar Institute of Experimental Medicine Department of Genetics , Istanbul University , Istanbul , Turkey.; c Department of Medical Genetics, School of Medicine , Acıbadem Mehmet Ali Aydınlar University , Istanbul , Turkey.

Publikováno v: Leukemia & lymphoma [Leuk Lymphoma] 2019 Jan; Vol. 60 (1), pp. 200-207. Date of Electronic Publication: 2018 Jul 02.

Third-line treatment with second-generation tyrosine kinase inhibitors (dasatinib or nilotinib) in patients with chronic myeloid leukemia after two prior TKIs: real-life data on a single center experience along with the review of the literature.

Autor: Ongoren S; a Division of Hematology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine , Istanbul University , Istanbul , Turkey., Eskazan AE; a Division of Hematology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine , Istanbul University , Istanbul , Turkey., Suzan V; b Department of Internal Medicine, Cerrahpasa Faculty of Medicine , Istanbul University , Istanbul , Turkey., Savci S; b Department of Internal Medicine, Cerrahpasa Faculty of Medicine , Istanbul University , Istanbul , Turkey., Erdogan Ozunal I; a Division of Hematology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine , Istanbul University , Istanbul , Turkey., Berk S; a Division of Hematology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine , Istanbul University , Istanbul , Turkey., Yalniz FF; a Division of Hematology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine , Istanbul University , Istanbul , Turkey., Elverdi T; a Division of Hematology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine , Istanbul University , Istanbul , Turkey., Salihoglu A; a Division of Hematology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine , Istanbul University , Istanbul , Turkey., Erbilgin Y; c Department of Genetics, Institute of Experimental Medicine (DETAE) , Istanbul University , Istanbul , Turkey., Iseri SA; c Department of Genetics, Institute of Experimental Medicine (DETAE) , Istanbul University , Istanbul , Turkey., Ar MC; a Division of Hematology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine , Istanbul University , Istanbul , Turkey., Baslar Z; a Division of Hematology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine , Istanbul University , Istanbul , Turkey., Aydin Y; a Division of Hematology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine , Istanbul University , Istanbul , Turkey., Tuzuner N; d Department of Pathology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine , Istanbul University , Istanbul , Turkey., Ozbek U; c Department of Genetics, Institute of Experimental Medicine (DETAE) , Istanbul University , Istanbul , Turkey., Soysal T; a Division of Hematology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine , Istanbul University , Istanbul , Turkey.

Publikováno v: Hematology (Amsterdam, Netherlands) [Hematology] 2018 May; Vol. 23 (4), pp. 212-220. Date of Electronic Publication: 2017 Oct 09.